Annual EBITDA
$10.49 B
+$364.00 M+3.59%
31 December 2023
Summary:
Elevance Health annual earnings before interest, taxes, depreciation & amortization is currently $10.49 billion, with the most recent change of +$364.00 million (+3.59%) on 31 December 2023. During the last 3 years, it has risen by +$2.31 billion (+28.30%). ELV annual EBITDA is now at all-time high.ELV EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$2.00 B
-$1.60 B-44.40%
30 September 2024
Summary:
Elevance Health quarterly earnings before interest, taxes, depreciation & amortization is currently $2.00 billion, with the most recent change of -$1.60 billion (-44.40%) on 30 September 2024. Over the past year, it has dropped by -$337.00 million (-14.41%). ELV quarterly EBITDA is now -59.29% below its all-time high of $4.92 billion, reached on 31 December 2009.ELV Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$10.82 B
-$337.00 M-3.02%
30 September 2024
Summary:
Elevance Health TTM earnings before interest, taxes, depreciation & amortization is currently $10.82 billion, with the most recent change of -$337.00 million (-3.02%) on 30 September 2024. Over the past year, it has increased by +$269.00 million (+2.55%). ELV TTM EBITDA is now -3.02% below its all-time high of $11.16 billion, reached on 30 June 2024.ELV TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELV EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.6% | -14.4% | +2.5% |
| 3 y3 years | +28.3% | -21.4% | +18.2% |
| 5 y5 years | +50.9% | +1.4% | +47.2% |
ELV EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +28.3% | -44.4% | +18.9% | -3.0% | +18.2% |
| 5 y | 5 years | at high | +50.9% | -44.9% | +123.7% | -3.0% | +47.2% |
| alltime | all time | at high | +4005.7% | -59.3% | +545.8% | -3.0% | >+9999.0% |
Elevance Health EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.00 B(-44.4%) | $10.82 B(-3.0%) |
| June 2024 | - | $3.60 B(+1.9%) | $11.16 B(+4.4%) |
| Mar 2024 | - | $3.54 B(+109.9%) | $10.69 B(+1.9%) |
| Dec 2023 | $10.49 B(+3.6%) | $1.68 B(-28.0%) | $10.49 B(-0.6%) |
| Sept 2023 | - | $2.34 B(-25.4%) | $10.55 B(-4.1%) |
| June 2023 | - | $3.13 B(-5.9%) | $11.01 B(+3.9%) |
| Mar 2023 | - | $3.33 B(+90.7%) | $10.59 B(+4.6%) |
| Dec 2022 | $10.13 B(+0.3%) | $1.75 B(-37.4%) | $10.13 B(-2.7%) |
| Sept 2022 | - | $2.79 B(+2.5%) | $10.41 B(+2.4%) |
| June 2022 | - | $2.72 B(-5.0%) | $10.17 B(-1.4%) |
| Mar 2022 | - | $2.87 B(+41.1%) | $10.31 B(+2.1%) |
| Dec 2021 | $10.10 B(+23.5%) | $2.03 B(-20.3%) | $10.10 B(+10.2%) |
| Sept 2021 | - | $2.55 B(-11.1%) | $9.16 B(+22.0%) |
| June 2021 | - | $2.87 B(+8.2%) | $7.50 B(-9.3%) |
| Mar 2021 | - | $2.65 B(+142.7%) | $8.27 B(+1.2%) |
| Dec 2020 | $8.18 B(+4.0%) | $1.09 B(+22.0%) | $8.18 B(-5.1%) |
| Sept 2020 | - | $895.00 M(-75.4%) | $8.62 B(-11.1%) |
| June 2020 | - | $3.64 B(+42.4%) | $9.70 B(+21.3%) |
| Mar 2020 | - | $2.55 B(+66.4%) | $8.00 B(+1.7%) |
| Dec 2019 | $7.86 B(+13.1%) | $1.53 B(-22.3%) | $7.86 B(+7.0%) |
| Sept 2019 | - | $1.98 B(+2.1%) | $7.35 B(+3.6%) |
| June 2019 | - | $1.93 B(-20.1%) | $7.09 B(-0.7%) |
| Mar 2019 | - | $2.42 B(+137.4%) | $7.14 B(+2.7%) |
| Dec 2018 | $6.95 B(+24.3%) | $1.02 B(-40.6%) | $6.95 B(+7.8%) |
| Sept 2018 | - | $1.72 B(-13.3%) | $6.45 B(+3.6%) |
| June 2018 | - | $1.98 B(-11.3%) | $6.22 B(+6.3%) |
| Mar 2018 | - | $2.23 B(+332.9%) | $5.86 B(+4.7%) |
| Dec 2017 | $5.59 B(-9.6%) | $516.00 M(-65.4%) | $5.59 B(-9.0%) |
| Sept 2017 | - | $1.49 B(-7.6%) | $6.15 B(-0.7%) |
| June 2017 | - | $1.61 B(-18.1%) | $6.19 B(-3.8%) |
| Mar 2017 | - | $1.97 B(+84.5%) | $6.44 B(+4.0%) |
| Dec 2016 | $6.19 B(-0.0%) | $1.07 B(-30.5%) | $6.19 B(+4.8%) |
| Sept 2016 | - | $1.54 B(-17.3%) | $5.91 B(+4.8%) |
| June 2016 | - | $1.86 B(+7.9%) | $5.63 B(-5.8%) |
| Mar 2016 | - | $1.72 B(+119.6%) | $5.98 B(-3.4%) |
| Dec 2015 | $6.19 B(+6.4%) | $785.30 M(-37.9%) | $6.19 B(-7.0%) |
| Sept 2015 | - | $1.27 B(-42.6%) | $6.66 B(-2.7%) |
| June 2015 | - | $2.20 B(+13.7%) | $6.84 B(+9.2%) |
| Mar 2015 | - | $1.94 B(+55.2%) | $6.26 B(+7.6%) |
| Dec 2014 | $5.82 B(+8.7%) | $1.25 B(-13.9%) | $5.82 B(+7.3%) |
| Sept 2014 | - | $1.45 B(-10.9%) | $5.42 B(+3.6%) |
| June 2014 | - | $1.63 B(+9.0%) | $5.24 B(+0.8%) |
| Mar 2014 | - | $1.49 B(+74.9%) | $5.20 B(-2.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | $5.35 B(+4.7%) | $853.40 M(-32.4%) | $5.35 B(+0.7%) |
| Sept 2013 | - | $1.26 B(-20.5%) | $5.32 B(-1.6%) |
| June 2013 | - | $1.59 B(-3.6%) | $5.40 B(+4.6%) |
| Mar 2013 | - | $1.65 B(+101.3%) | $5.16 B(+1.0%) |
| Dec 2012 | $5.11 B(+1.7%) | $818.80 M(-39.2%) | $5.11 B(+1.0%) |
| Sept 2012 | - | $1.35 B(-0.1%) | $5.06 B(+0.8%) |
| June 2012 | - | $1.35 B(-15.6%) | $5.02 B(+1.7%) |
| Mar 2012 | - | $1.60 B(+107.3%) | $4.94 B(-1.7%) |
| Dec 2011 | $5.03 B(-6.5%) | $770.60 M(-41.0%) | $5.03 B(-4.8%) |
| Sept 2011 | - | $1.31 B(+3.1%) | $5.28 B(-1.7%) |
| June 2011 | - | $1.27 B(-24.8%) | $5.37 B(-2.0%) |
| Mar 2011 | - | $1.68 B(+64.5%) | $5.48 B(+2.0%) |
| Dec 2010 | $5.37 B(-36.1%) | $1.02 B(-26.8%) | $5.37 B(-42.0%) |
| Sept 2010 | - | $1.40 B(+1.6%) | $9.27 B(+1.6%) |
| June 2010 | - | $1.38 B(-12.5%) | $9.12 B(+2.0%) |
| Mar 2010 | - | $1.57 B(-68.0%) | $8.94 B(+6.4%) |
| Dec 2009 | $8.40 B(+101.8%) | $4.92 B(+292.1%) | $8.40 B(+82.6%) |
| Sept 2009 | - | $1.25 B(+4.9%) | $4.60 B(+13.8%) |
| June 2009 | - | $1.20 B(+15.4%) | $4.04 B(-3.2%) |
| Mar 2009 | - | $1.04 B(-7.2%) | $4.18 B(+0.3%) |
| Dec 2008 | $4.16 B(-28.5%) | $1.12 B(+60.8%) | $4.16 B(-8.0%) |
| Sept 2008 | - | $694.60 M(-47.7%) | $4.52 B(-15.4%) |
| June 2008 | - | $1.33 B(+29.7%) | $5.35 B(-2.2%) |
| Mar 2008 | - | $1.02 B(-30.7%) | $5.47 B(-6.1%) |
| Dec 2007 | $5.83 B(+6.9%) | $1.48 B(-2.8%) | $5.83 B(+7.6%) |
| Sept 2007 | - | $1.52 B(+4.9%) | $5.42 B(+0.1%) |
| June 2007 | - | $1.45 B(+4.9%) | $5.41 B(-2.2%) |
| Mar 2007 | - | $1.38 B(+29.5%) | $5.53 B(+1.5%) |
| Dec 2006 | $5.45 B(+14.7%) | $1.07 B(-29.4%) | $5.45 B(-9.6%) |
| Sept 2006 | - | $1.51 B(-3.8%) | $6.03 B(+7.2%) |
| June 2006 | - | $1.57 B(+20.7%) | $5.63 B(+11.5%) |
| Mar 2006 | - | $1.30 B(-20.8%) | $5.05 B(+6.2%) |
| Dec 2005 | $4.75 B(+154.7%) | $1.64 B(+48.2%) | $4.75 B(+30.1%) |
| Sept 2005 | - | $1.11 B(+11.8%) | $3.65 B(+25.0%) |
| June 2005 | - | $991.90 M(-1.3%) | $2.92 B(+22.4%) |
| Mar 2005 | - | $1.01 B(+84.1%) | $2.39 B(+28.1%) |
| Dec 2004 | $1.86 B(+629.8%) | $546.10 M(+44.1%) | $1.86 B(+41.4%) |
| Sept 2004 | - | $379.10 M(-17.1%) | $1.32 B(+40.4%) |
| June 2004 | - | $457.50 M(-5.1%) | $939.50 M(+94.9%) |
| Mar 2004 | - | $482.00 M(-207.3%) | $482.00 M(+445.2%) |
| Dec 2002 | $255.50 M | -$449.10 M(-247.3%) | $88.40 M(-83.6%) |
| Sept 2002 | - | $304.80 M(+31.0%) | $537.50 M(+131.0%) |
| June 2002 | - | $232.70 M | $232.70 M |
FAQ
- What is Elevance Health annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Elevance Health?
- What is Elevance Health annual EBITDA year-on-year change?
- What is Elevance Health quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Elevance Health?
- What is Elevance Health quarterly EBITDA year-on-year change?
- What is Elevance Health TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Elevance Health?
- What is Elevance Health TTM EBITDA year-on-year change?
What is Elevance Health annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ELV is $10.49 B
What is the all time high annual EBITDA for Elevance Health?
Elevance Health all-time high annual earnings before interest, taxes, depreciation & amortization is $10.49 B
What is Elevance Health annual EBITDA year-on-year change?
Over the past year, ELV annual earnings before interest, taxes, depreciation & amortization has changed by +$364.00 M (+3.59%)
What is Elevance Health quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ELV is $2.00 B
What is the all time high quarterly EBITDA for Elevance Health?
Elevance Health all-time high quarterly earnings before interest, taxes, depreciation & amortization is $4.92 B
What is Elevance Health quarterly EBITDA year-on-year change?
Over the past year, ELV quarterly earnings before interest, taxes, depreciation & amortization has changed by -$337.00 M (-14.41%)
What is Elevance Health TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ELV is $10.82 B
What is the all time high TTM EBITDA for Elevance Health?
Elevance Health all-time high TTM earnings before interest, taxes, depreciation & amortization is $11.16 B
What is Elevance Health TTM EBITDA year-on-year change?
Over the past year, ELV TTM earnings before interest, taxes, depreciation & amortization has changed by +$269.00 M (+2.55%)